210 related articles for article (PubMed ID: 27867015)
1. CMTM3 decreases EGFR expression and EGF-mediated tumorigenicity by promoting Rab5 activity in gastric cancer.
Yuan W; Liu B; Wang X; Li T; Xue H; Mo X; Yang S; Ding S; Han W
Cancer Lett; 2017 Feb; 386():77-86. PubMed ID: 27867015
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
[TBL] [Abstract][Full Text] [Related]
3. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
4. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
[TBL] [Abstract][Full Text] [Related]
5. miR-135b-5p promotes gastric cancer progression by targeting CMTM3.
Lu M; Huang Y; Sun W; Li P; Li L; Li L
Int J Oncol; 2018 Feb; 52(2):589-598. PubMed ID: 29345297
[TBL] [Abstract][Full Text] [Related]
6. CMTM3 inhibits cell migration and invasion and correlates with favorable prognosis in gastric cancer.
Su Y; Lin Y; Zhang L; Liu B; Yuan W; Mo X; Wang X; Li H; Xing X; Cheng X; Dong B; Hu Y; Du H; Zhu Y; Ding N; Li J; Liu W; Ma Y; Qiu X; Ji J; Han W
Cancer Sci; 2014 Jan; 105(1):26-34. PubMed ID: 24131472
[TBL] [Abstract][Full Text] [Related]
7. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
8. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.
Barbieri MA; Roberts RL; Gumusboga A; Highfield H; Alvarez-Dominguez C; Wells A; Stahl PD
J Cell Biol; 2000 Oct; 151(3):539-50. PubMed ID: 11062256
[TBL] [Abstract][Full Text] [Related]
10. Engagement of the small GTPase Rab31 protein and its effector, early endosome antigen 1, is important for trafficking of the ligand-bound epidermal growth factor receptor from the early to the late endosome.
Chua CE; Tang BL
J Biol Chem; 2014 May; 289(18):12375-89. PubMed ID: 24644286
[TBL] [Abstract][Full Text] [Related]
11. Expression of dominant negative rab5 in HeLa cells regulates endocytic trafficking distal from the plasma membrane.
Dinneen JL; Ceresa BP
Exp Cell Res; 2004 Apr; 294(2):509-22. PubMed ID: 15023538
[TBL] [Abstract][Full Text] [Related]
12. [Knockdown of CMTM3 promotes migration and invasion of PC3 cell in vitro].
Hu FZ; Yuan WQ; Wang XL; Qin CP; Sheng ZZ; DU YQ; Yin HQ; Xu T
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):594-597. PubMed ID: 29263495
[TBL] [Abstract][Full Text] [Related]
13. A role for sorting nexin 2 in epidermal growth factor receptor down-regulation: evidence for distinct functions of sorting nexin 1 and 2 in protein trafficking.
Gullapalli A; Garrett TA; Paing MM; Griffin CT; Yang Y; Trejo J
Mol Biol Cell; 2004 May; 15(5):2143-55. PubMed ID: 14978220
[TBL] [Abstract][Full Text] [Related]
14. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
[TBL] [Abstract][Full Text] [Related]
15. Regulation of intracellular trafficking of the EGF receptor by Rab5 in the absence of phosphatidylinositol 3-kinase activity.
Chen X; Wang Z
EMBO Rep; 2001 Jan; 2(1):68-74. PubMed ID: 11252727
[TBL] [Abstract][Full Text] [Related]
16. CMTM3 suppresses chordoma progress through EGFR/STAT3 regulated EMT and TP53 signaling pathway.
Yuan W; Wei F; Ouyang H; Ren X; Hang J; Mo X; Liu Z
Cancer Cell Int; 2021 Sep; 21(1):510. PubMed ID: 34560882
[TBL] [Abstract][Full Text] [Related]
17. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
18. CMTM7 as a novel molecule of ATG14L-Beclin1-VPS34 complex enhances autophagy by Rab5 to regulate tumorigenicity.
Liu B; Lu Y; Zhang T; Yu X; Wang Q; Chi Y; Jin S; Cheng G
Cell Commun Signal; 2021 Jul; 19(1):77. PubMed ID: 34281589
[TBL] [Abstract][Full Text] [Related]
19. Research Advances in CKLFSF-like MARVEL Transmembrane Domain Containing Member 3.
Hu FZ; Sheng ZZ; Qin CP; Xu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):360-3. PubMed ID: 27469927
[TBL] [Abstract][Full Text] [Related]
20. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
Li W; Zhang S
Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
